MS-Selfie

Home
Notes
MS-Selfie Research
MS-Selfie Microsite
Contact
Q&A
Archive
Leaderboard
About
Q&A-5 for paid subscribers
When to flip the pyramid? What new MS therapies are interesting? Brain volume loss in clinical practice?
 • 
Gavin Giovannoni
5
New
Top
Community
Cladribine
Cladribine is a selective immune reconstitution therapy (IRT) and is the only IRT on the WHO List of Essential Medicines for treating multiple…
 • 
Gavin Giovannoni
30
Q&A session 4 for paid subscribers
How many people clear EBV from having AHSCT? ... Regarding anti-CD20 therapies, would you recommend ocrelizumab (Ocrevus) or ofatumumab (Kesimpta)?
 • 
Gavin Giovannoni
13
Is the neurological examination obsolete?
I recently saw a new neurologist when I relapsed. He did a cursory examination that took two or three minutes and told me my EDSS was 4.5. Is it…
 • 
Gavin Giovannoni
46
Q&A session 3 for paid subscribers
Will the ATARA-Bio's trial of ATA188 be positive? Does rituximab get into the CNS and kill EBV-infected B-cells? Are sebaceous cysts and rosacea…
 • 
Gavin Giovannoni
16
Is there a need for MS self-management flowcharts or algorithms?
Listen now (12 mins) | The issues people with MS have regarding their long-term management are not too dissimilar to patients with dementia....
 • 
Gavin Giovannoni
62
Q&A-2 session for paid subscribers
Listen now (2 mins) | Siponimod or not? To start a DMT or wait? T-cell and B-cell repopulation post-HSCT?
 • 
Gavin Giovannoni
27
Multiple sclerosis and seizures
Listen now (16 mins) | Seizures and epilepsy (recurrent unprovoked seizures) are relatively common in people with MS. In the MS-Selfie podcast and…
 • 
Gavin Giovannoni
12
MS-Selfie
MS-Selfie
MS-Selfie helps you self-manage your multiple sclerosis. MS-Selfie consists of the newsletter and the MS-Selfie microsite, which consists of curated content https://msselfie.co.uk/

MS-Selfie

AboutArchiveSitemap
© 2023 Gavin Giovannoni
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing